Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) stock fell -2.64% on Friday to $8.84 against a previous-day closing price of $9.08. With 1.53 million shares changed hands, the volume of the stock remained lighter than its average volume of 2.14 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $9.12 whereas the lowest price it dropped to was $8.83. The 52-week range on AUPH shows that it touched its highest point at $12.43 and its lowest point at $4.07 during that stretch. It currently has a 1-year price target of $14.00. Beta for the stock currently stands at 1.25.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of AUPH was down-trending over the past week, with a drop of -10.07%, but this was down by -9.24% over a month. Three-month performance dropped to -10.98% while six-month performance fell -7.63%. The stock gained 18.02% in the past year, while it has gained 104.63% so far this year. A look at the trailing 12-month EPS for AUPH yields -0.51 with Next year EPS estimates of -0.33. For the next quarter, that number is -0.17. This implies an EPS growth rate of 45.50% for this year and 41.10% for next year.
Float and Shares Shorts:
At present, 142.78 million AUPH shares are outstanding with a float of 133.37 million shares on hand for trading. On Aug 30, 2023, short shares totaled 13.96 million, which was 9.73% higher than short shares on Jul 30, 2023. In addition to Mr. Peter S. Greenleaf M.B.A. as the firm’s Pres, CEO & Director, Mr. Joseph M. Miller CPA serves as its Chief Financial Officer.
Institutional Ownership:
Through their ownership of 38.06% of AUPH’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 23.97% of AUPH, in contrast to 11.76% held by mutual funds. Shares owned by individuals account for 0.51%. As the largest shareholder in AUPH with 4.87% of the stake, BlackRock Fund Advisors holds 6,990,867 shares worth 6,990,867. A second-largest stockholder of AUPH, Armistice Capital LLC, holds 4,692,000 shares, controlling over 3.27% of the firm’s shares. SSgA Funds Management, Inc. is the third largest shareholder in AUPH, holding 2,632,486 shares or 1.84% stake. With a 2.12% stake in AUPH, the iShares Russell 2000 ETF is the largest stakeholder. A total of 3,036,850 shares are owned by the mutual fund manager. The Fidelity Small Cap Index Fund, which owns about 0.83% of AUPH stock, is the second-largest Mutual Fund holder. It holds 1,194,083 shares valued at 10.83 million. iShares Russell 2000 Growth ETF holds 0.80% of the stake in AUPH, owning 1,152,405 shares worth 10.45 million.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Jun 29, 2023, AUPH reported revenue of $28.19M and operating income of -$35.99M. The EBITDA in the recently reported quarter was -$35.15M and diluted EPS was -$0.25.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for AUPH since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With AUPH analysts setting a high price target of $15.00 and a low target of $12.00, the average target price over the next 12 months is $14.00. Based on these targets, AUPH could surge 69.68% to reach the target high and rise by 35.75% to reach the target low. Reaching the average price target will result in a growth of 58.37% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
Summary of Insider Activity:
Insiders traded AUPH stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 42 while that of sell transactions has risen to 8 over the past year. The total number of shares bought during that period was 2,295,739 while 86,904 shares were sold.
